- A Phase I Study of CNF2024 Alone in Patients with HER2-Negative Advanced Breast Cancer or with Trastuzumab in Patients with HER2-Positive Advanced Breast Cancer
Modi, Shanu, MD
[Protocol 07-123]
- A Phase I Study of COX-2 Inhibition and Aromatase Activity in Breast Cancer
Port, Elisa, MD
[Protocol 03-027]
- A Phase I Study of Her2/neu DNA Immunization for Patients with Metastatic or High-Risk Breast Cancer
Gilewski, Teresa, MD
[Protocol 04-101]
- A Phase I/II Clinical Trial of KOS-953 (17-AAG) and Trastuzumab (Herceptin®) in Patients with Metastatic Breast Cancer
Hudis, Clifford, MD
[Protocol 04-114]
- A Phase I/II Study of BMS-753493 in Patients with Advanced Cancer
Konner, Jason, MD
[Protocol 08-032]
- A Phase I/II Study of Biweekly Capecitabine for the Treatment of
Metastatic Breast Cancer
Traina, Tiffany, MD
[Protocol 05-030]
- A Phase II Study of AZD0530 in Hormone Receptor-Negative Metastatic Breast Cancer or Unresectable Locally Advanced Breast Cancer
Hudis, Clifford, MD
[Protocol 07-112]
- A Phase II Study of Bicalutamide for the Treatment of Androgen Receptor-Positive, Estrogen and Progesterone Receptor-Negative Metastatic Breast Cancer
Hudis, Clifford, MD
[Protocol 07-022]
- A Phase II Study of Ertumaxomab in Patients with HER-2-Positive Metastatic Breast Cancer Progressing after Trastuzumab Treatment
Modi, Shanu, MD
[Protocol 07-155]
- A Phase II Study of KU-0059436 in Patients with Advanced BRCA1- or BRCA2-Associated Breast Cancer
Robson, Mark, MD
[Protocol 07-117]
- A Phase II Trial Comparing Three Different Treatment Schedules of ABI-007 in Combination with Bevacizumab in Women with Metastatic Breast Cancer
Seidman, Andrew, MD
[Protocol 06-025]
- A Phase II Trial of Patupilone in Patients with Brain Metastases from Breast Cancer
Seidman, Andrew, MD
[Protocol 07-036]
- A Phase III Study of Conventional Whole Breast Irradiation Versus Partial Breast Irradiation for Women with Early-Stage Breast Cancer
McCormick, Beryl, MD
[Protocol 05-068]
- A Phase III Study of Fulvestrant with or without Lapatinib (Tykerb®) for Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer
Lake, Diana, MD
[Protocol 07-122]
- A Phase III Study of the Continued Safety and Effectiveness of Zometa® in Patients with Bone Metastases from Breast Cancer
Fornier, Monica, MD
[Protocol 06-119]
- A Phase III Trial of Cyclophosphamide and Doxorubicin versus Paclitaxel as Adjuvant Therapy for Women with Node-Negative Breast Cancer
Lake, Diana, MD
[Protocol 04-042]
- A Phase III Trial of Doxorubicin and Cyclophosphamide followed by Paclitaxel with or without Bevacizumab in Patients with Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer
Dang, Chau, MD
[Protocol 08-035]
- A Phase IIb Study of Gemcitabine with or without Sorafenib in Women with Locally Advanced or Metastatic Breast Cancer that has Progressed During or After Bevacizumab Therapy
Hudis, Clifford, MD
[Protocol 07-131]
- A Pilot Study of Dose-Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, and Fluorouracil) at 14-Day Intervals for Women with Early Breast Cancer
Drullinsky, Pamela, MD
[Protocol 07-133]
- A Prospective, Longitudinal Study to Examine Time-Dependent Neurocognitive Changes in Patients with Breast Cancer Receiving Adjuvant Chemotherapy
Ahles, Tim, PhD
[Protocol 07-130]
- A Study Assessing the Use of AlloDerm in Two-Stage, Tissue Expander/Implant Breast Reconstruction
Disa, Joseph, MD
[Protocol 08-024]
- A Study of Positron Emission Tomography (PET) Scanning for the Pre-Operative Evaluation of Patients with Primary and Recurrent Breast Carcinoma
Port, Elisa, MD
[Protocol 01-134]
- A Survey of Sleep Problems in Survivors of Early-Stage Breast Cancer
Passik, Steven, PhD
[Protocol 06-071]
- Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer
Dang, Chau, MD
[Protocol 08-017]
- Assessing Depression in a Geriatric Cancer Population
Nelson, Christian, PhD
[Protocol 06-100]
- BRCA1 Haploinsufficiency and Gene Expression
King, Tari, MD
[Protocol 04-045]
- Breast MRI as a Preoperative Tool for DCIS
Van Zee, Kimberly, MD
[Protocol 06-124]
- Chemotherapy Decisions and Outcomes in Women Age 65 or Older with Operable, Newly Diagnosed Breast Cancer
Lake, Diana, MD
[Protocol 04-030]
- Chemotherapy-Induced Changes in Cognition and DNA in Breast Cancer Survivors
Ahles, Tim, PhD
[Protocol 07-090]
- Clinical Outcomes in Hereditary Cancer
Robson, Mark, MD
[Protocol 06-004]
- Clinical Significance of Germline BRCA Mutations
Offit, Kenneth, MD
[Protocol 96-051]
- Clinical Study of McGhan Corporation Style 410 Silicone-Filled Breast Implants
Disa, Joseph, MD
[Protocol 06-024]
- Contrast-Enhanced Breast MRI Evaluation of Patients Undergoing Neoadjuvant Treatment for Locally Advanced Breast Cancer
Morris, Elizabeth, MD
[Protocol 03-019]
- Cytologic Analysis of Ductal Lavage Specimens
Montgomery, Leslie, MD
[Protocol 01-101]
- Decision-Making Regarding Prophylactic Mastectomy & Oophorectomy in Women Seeking Genetic Testing for Inherited BRCA1 and BRCA2 Mutations
Hurley, Karen, PhD
[Protocol 03-001]
- Immunization of High-Risk Breast Cancer Patients with a Sialyl Lewisa-Keyhole Limpet Hemocyanin Conjugate plus the Immunological Adjuvant QS-21
Gilewski, Teresa, MD
[Protocol 06-156]
- Inamed Corporation Style 410 Silicone-Filled Breast Implant Continued Assess Reconstruction/Revision Expansion (CARE) Clinical Study
Cordeiro, Peter, MD
[Protocol 06-076]
- International Breast Reconstruction Outcomes Study (IBROC) Pilot 1
Pusic, Andrea, MD, MHS
[Protocol 08-036]
- Measuring Patient Expectations for Breast Reconstruction
Pusic, Andrea, MD, MHS
[Protocol 07-024]
- Measuring Patient Satisfaction in Breast Surgery: Development and Validation of a Patient-Reported Outcomes Instrument
Pusic, Andrea, MD, MHS
[Protocol 05-058]
- Molecular Mechanisms of Clinical Resistance to Anti-HER2 Therapy Among Patients with HER2-Amplified Breast Cancer
Hudis, Clifford, MD
[Protocol 06-163]
- Pharmacogenetics of Aromatase Inhibitors
Robson, Mark, MD
[Protocol 07-132]
- Quantification of Sensation Following Postmastectomy Breast Reconstruction
Mehrara, Babak, MD
[Protocol 06-047]
- Sensory Morbidity Following Breast Surgery
Pusic, Andrea, MD, MHS
[Protocol 08-009]
- Use of Breast MRI & Biomarker Studies to Characterize Tumor Response in Patients Receiving Neoadjuvant Treatment for Locally Advanced Breast Cancer
Montgomery, Leslie, MD
[Protocol 02-086]
|
